Edesa Biotech Inc — Balance Sheet (NASDAQ:EDSA) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Total assets 10.76 M14.58 M11.58 M8.89 M3.81 M13.53 M Total liabilities 1.65 M1.53 M2.18 M1.84 M1.83 M1.08 M Total equity 6.63 M13.06 M9.39 M7.05 M1.98 M12.45 M Total liabilities & shareholders' equities 10.76 M14.58 M11.58 M8.89 M3.81 M13.53 M Total debt —————— Net debt ——————

Новости

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.76%

Рынок акций США закрылся ростом, Dow Jones прибавил 0,76%

Акции Edesa Biotech взлетели на позитивных данных 3 фазы

Edesa Biotech stock surges on positive Phase 3 trial data

Edesa Biotech reports mortality reduction in phase 3 trial

Edesa Biotech увеличивает лимит предложения ATM до $2,26 млн

Edesa Biotech increases at-the-market offering limit to $2.26 million

Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025 - Slideshow (NASDAQ:EDSA) 2025-11-17

Edesa Biotech сообщает о положительных результатах 3 фазы для препарата от ОРДС

Edesa’s ARDS drug shows 25% reduction in death risk in phase 3 trial

Edesa Biotech reports positive Phase 3 results for ARDS drug candidate

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results